Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pramipexole in Children and Adolescents with Tourette Disorder
NCT00558467Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jan 2008
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of pramipexole in Tourette syndrome (TS), sponsored by Boehringer Ingelheim. Started Jan 2008; status: completed.
02
Drugs
pramipexole
03
Conditions
Tourette syndrome (TS)
Beyond the preview
Go deeper on NCT00558467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00558467.